Literature DB >> 12026754

Individualizing treatment decisions. The likelihood of being helped or harmed.

Sharon E Straus1.   

Abstract

Clinical decision making cannot rely on evidence alone. Although significant advances have occurred in the development of high-quality evidence, similar efforts must be made to develop and evaluate tools that can be used at the bedside to individualize treatment decisions and to facilitate the incorporation of our patients' unique values and circumstances into the decision-making process. These tools should express the helpful and harmful effects of treatment, and it must be possible to modify these statements using patients' values. Finally, this process should be accomplished in real time in a busy clinical practice. In this article, the author outlines some of these decision support tools, describes an attempt to meet some of the challenges inherent in the goal of achieving effective shared decision making, and proposes a patient-centered measure of the likelihood of being helped and harmed by an intervention and discusses its derivation and an evaluation of its usefulness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026754     DOI: 10.1177/016327870202500206

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  17 in total

1.  The "number needed to treat" turns 20--and continues to be used and misused.

Authors:  Finlay A McAlister
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

2.  Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

Authors:  Federica Cuppone; Emilio Bria; Vanja Vaccaro; Fabio Puglisi; Alessandra Fabi; Isabella Sperduti; Paolo Carlini; Michele Milella; Cecilia Nisticò; Michelangelo Russillo; Paola Papaldo; Gianluigi Ferretti; Matti Aapro; Diana Giannarelli; Francesco Cognetti
Journal:  J Exp Clin Cancer Res       Date:  2011-05-12

3.  Contextual factors in clinical decision making: national survey of Canadian family physicians.

Authors:  C Shawn Tracy; Guilherme Coelho Dantas; Rahim Moineddin; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

Review 4.  When should patient intuition be taken seriously?

Authors:  Stephen A Buetow; Bridget Mintoft
Journal:  J Gen Intern Med       Date:  2010-11-23       Impact factor: 5.128

Review 5.  Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.

Authors:  E Bria; M Milella; F Cuppone; S Novello; A Ceribelli; V Vaccaro; I Sperduti; A Gelibter; G V Scagliotti; F Cognetti; D Giannarelli
Journal:  Ann Oncol       Date:  2011-02-16       Impact factor: 32.976

Review 6.  Describing treatment effects to patients.

Authors:  Annette Moxey; Dianne O'Connell; Patricia McGettigan; David Henry
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

7.  [Tree decision analysis of the therapeutic alternatives for Panic Disorders in Primary Care].

Authors:  Fernando Navarro-Mateu; Ascensión Garriga-Puerto; Juan Antonio Sánchez-Sánchez
Journal:  Aten Primaria       Date:  2009-07-24       Impact factor: 1.137

8.  Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm.

Authors:  Leslie Citrome; Yangchun Du; Peter J Weiden
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-12       Impact factor: 2.570

9.  A tool to balance benefit and harm when deciding about adjuvant therapy.

Authors:  A M Knops; A Goossens; M P M Burger; L J A Stalpers; D T Ubbink
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

10.  Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses.

Authors:  Hui Ju Chih; Flavia T S Elias; Laura Gaudet; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-28       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.